Gut feel leads Microbiotica to new HQ
Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, is relocating to Chesterford Research Park from the Wellcome Genome Campus in a two-phase move that will be completed in June 2020.
Microbiotica’s continuing development and expansion and the ability of the research park to flexibly accommodate its immediate and longer-term growth requirements led to the decision by the Cambridge company.
Under the first phase of the relocation, Microbiotica is taking two suites within the Science Village, a short-term solution to facilitate current growth requirements.
Until June 2020 Microbiotica will retain its current premises at the Wellcome Genome Campus, at which point the whole organisation will move into its own purpose designed facilities in the Newnham Building at Chesterford, which is currently undergoing reconfiguration and refurbishment.
Mike Romanos, co-founder and CEO, Microbiotica said: “Following a period of rapid progress we require a new facility to support our current growth trajectory and to allow us to consolidate our whole team in one building.
“It is also important for us to stay in the Cambridge area and to continue to play an active role in the Cambridge life sciences cluster community. Chesterford Research Park has provided us with a solution for our immediate short-term expansion, which was important before our permanent facility, tailored to suit our future needs, is ready in Summer 2020.
‘We very much appreciate the flexibility that Chesterford Research Park has shown us.”
There has been a high level of interest in the Newnham Building. Confirmation of Microbiotica’s pre-let, coupled with the recent announcement that existing park occupier, Isomerase is also committed to a suite, leaves just one 11,518 sq ft suite. This is being marketed by Savills and Cheffins.